Digniin cusub oo ku saabsan ka-hortagga niyad-jabka

Qanacsan

• Dib u eegis loogu talagalay

Haddii aad qaadato mid ka mid ah dawooyinka ka-hortagga niyad-jabka ee inta badan laguu qoro, dhakhtarkaagu wuxuu bilaabi karaa inuu si dhow kuu kormeero si loo arko calaamadaha niyad-jabkaagu sii xumaanayo, gaar ahaan marka aad bilowdo daaweynta ama qiyaastaada la beddelay. Maamulka Cuntada iyo Dawooyinka ee Maraykanka (FDA) ayaa dhowaan soo saaray la -talin arrintan ku saabsan, maaddaama daraasadaha iyo warbixinnada qaarkood ay soo jeedinayaan in daawooyinku kordhin karaan fikradaha is -dilka.10-ka xulashada serotonin reuptake inhibitors (SSRIs) iyo ilma adeer kiimikaad kuwaas oo diirada saaraya digniinta cusub waa Celexa (citalopram), Effexor (venlafaxine), Lexapro (escitalopram), Luvox (fluvoxamine), Paxil (paroxetine), Prozac (fluoxetine). ), Remeron (mirtazapine), Serzone (nefazodone), Wellbutrin (bupropion) iyo Zoloft (sertraline). Calaamadaha digniinta ee adiga iyo dhakhtarkaagu ay tahay inaad ogaataan waxaa ka mid ah kororka weerarada argagaxa, kacsanaanta, cadaawadda, welwelka iyo hurdo la’aanta, iyo kuwo kale.

In kasta oo ay tahay la-talinta cusub, ha joojin qaadashada ka-hortagga niyad-jabka. “Si lama filaan ah joojinta daawooyinka waxay uga sii dari kartaa xaaladda bukaanka,” ayay tiri Marcia Goin, MD, oo madax ka ah Ururka Cilmi -nafsiga Mareykanka. FDA waxay bixisaa macluumaad badbaado oo la cusboonaysiiyay www.fda.gov/cder/drug/antidepressants/.

Dib u eegis loogu talagalay